Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 24, 2018 (8 years ago)

Thyroid Powder

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Thyroid Powder, USP, 25kg/drum, Rx Only, Sichuan Friendly Pharmaceutical Co., LTD. NDC: 070870-1701-1

Drug: Thyroid Category: Thyroid Medication

Recalling firm
LGM Pharma LLC
Origin
KY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0296-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Thyroid recalls

See all
Class II · Moderate risk

Thyroid

Subpotent Drug

Ongoing Wrong potency / content Specialty Process Labs LLC NDC 81305-100-02 D-0294-2026
Class II · Moderate risk

S.P Labs

Failed Stability Specifications

Completed Stability / shelf life Specialty Process Labs LLC D-0447-2024
Class II · Moderate risk

S.P.Labs

Failed Stability Specifications

Completed Stability / shelf life Specialty Process Labs LLC NDC 81305-500-01 D-0446-2024

Other recalls by LGM Pharma LLC

All 2018 recalls
Class II · Moderate risk

Cidofovir Dihydrate

CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Terminated cGMP deviation LGM Pharma LLC D-0486-2019